Lim Wendy, Qushmaq Ismael, Cook Deborah J, Crowther Mark A, Heels-Ansdell Diane, Devereaux P J
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Crit Care. 2005;9(6):R636-44. doi: 10.1186/cc3816. Epub 2005 Sep 28.
Elevated troponin levels indicate myocardial injury but may occur in critically ill patients without evidence of myocardial ischemia. An elevated troponin alone cannot establish a diagnosis of myocardial infarction (MI), yet the optimal methods for diagnosing MI in the intensive care unit (ICU) are not established. The study objective was to estimate the frequency of MI using troponin T measurements, 12-lead electrocardiograms (ECGs) and echocardiography, and to examine the association of elevated troponin and MI with ICU and hospital mortality and length of stay.
In this 2-month single centre prospective cohort study, all consecutive patients admitted to our medical-surgical ICU were classified in duplicate by two investigators as having MI or no MI based on troponin, ECGs and echocardiograms obtained during the ICU stay. The diagnosis of MI was based on an adaptation of the joint European Society of Cardiology/American College of Cardiology definition: a typical rise or fall of an elevated troponin measurement, in addition to ischemic symptoms, ischemic ECG changes, a coronary artery intervention, or a new cardiac wall motion abnormality.
We screened 117 ICU admissions and enrolled 115 predominantly medical patients. Of these, 93 (80.9%) had at least one ECG and one troponin; 44 of these 93 (47.3%) had at least one elevated troponin and 24 (25.8%) had an MI. Patients with MI had significantly higher mortality in the ICU (37.5% versus 17.6%; P = 0.050) and hospital (50.0% versus 22.0%; P = 0.010) than those without MI. After adjusting for Acute Physiology and Chronic Health Evaluation II score and need for inotropes or vasopressors, MI was an independent predictor of hospital mortality (odds ratio 3.22, 95% confidence interval 1.04-9.96). The presence of an elevated troponin (among those patients in whom troponin was measured) was not independently predictive of ICU or hospital mortality.
In this study, 47% of critically ill patients had an elevated troponin but only 26% of these met criteria for MI. An elevated troponin without ischemic ECG changes was not associated with adverse outcomes; however, MI in the ICU setting was an independent predictor of hospital mortality.
肌钙蛋白水平升高提示心肌损伤,但在无心肌缺血证据的危重症患者中也可能出现。仅肌钙蛋白升高不能确诊心肌梗死(MI),然而,重症监护病房(ICU)中诊断MI的最佳方法尚未确立。本研究的目的是通过肌钙蛋白T检测、12导联心电图(ECG)和超声心动图评估MI的发生率,并探讨肌钙蛋白升高及MI与ICU和医院死亡率及住院时间的关系。
在这项为期2个月的单中心前瞻性队列研究中,两名研究人员根据入住ICU期间获得的肌钙蛋白、ECG和超声心动图,对所有入住我们内科-外科ICU的连续患者进行了两次重复分类,分为患有MI或未患MI。MI的诊断基于欧洲心脏病学会/美国心脏病学会联合定义的修订版:除了缺血症状、缺血性ECG改变、冠状动脉介入治疗或新出现的心脏壁运动异常外,肌钙蛋白测量值有典型的升高或降低。
我们筛查了117例入住ICU的患者,纳入了115例以内科患者为主的患者。其中,93例(80.9%)至少有一份ECG和一次肌钙蛋白检测;这93例患者中,44例(47.3%)至少有一次肌钙蛋白升高,24例(25.8%)患有MI。与未患MI的患者相比,患有MI的患者在ICU(37.5%对17.6%;P = 0.050)和医院(50.0%对22.0%;P = 0.010)的死亡率显著更高。在调整急性生理与慢性健康状况评分II以及对血管活性药物的需求后,MI是医院死亡率的独立预测因素(比值比3.22,95%置信区间1.04 - 9.96)。肌钙蛋白升高(在检测了肌钙蛋白的患者中)并非ICU或医院死亡率独立的预测因素。
在本研究中,47%的危重症患者肌钙蛋白升高,但其中只有26%符合MI标准。无缺血性ECG改变的肌钙蛋白升高与不良结局无关;然而,ICU环境中的MI是医院死亡率的独立预测因素。